Alphatec Holdings Inc.

Last updated September 27, 2026

Organization details

Legal name
Alphatec Holdings Inc.
Ownership
Public
Status
Active
SIC code
3841 — Surgical & Medical Instruments & Apparatus
Jurisdiction of incorporation
Delaware
Headquarters city
Carlsbad
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
ATEC
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001350653
EIN
20-2463898

Board of directors

Chief executives

Patrick Miles · CEO
Dates unknown

Director election results

Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

7 of this board's directors also sit on 12 other boards.

Network of Alphatec Holdings Inc.'s board connections iRhythm Holdings Inc. iRhythm Holdings Inc. Absci Corporation Absci Corporation Align Technology Inc. Align Technology Inc. Battalion Oil Corporation Battalion Oil Corporat... Crane Company Crane Company Crane NXT Co. Crane NXT Co. EVgo Inc. EVgo Inc. OrthoPediatrics Corp. OrthoPediatrics Corp. Orthofix Medical Inc. Orthofix Medical Inc. Pershing Square USA Ltd. Pershing Square USA Lt... Regentis Biomaterials Ltd. Regentis Biomaterials... SI-BONE Inc. SI-BONE Inc. David R. Pelizzon David R. Pelizzon Evan Bakst Evan Bakst James L. L. Tullis James L. L. Tullis Karen K. Mcginnis Karen K. Mcginnis Keith Valentine Keith Valentine Paul Segal Paul Segal Quentin S. Blackford Quentin S. Blackford Alphatec Holdings Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$2,009,342
4 purchases by 2 insiders
Sold, last 12 months
$97,160,438
44 sales by 13 insiders
Date Insider Transaction Shares Price Value
Sep 10, 2026 Patrick Miles Director, Officer (CEO) Open-market purchase +115,000 $8.81 $1,013,150
Aug 5, 2026 Marshall Tyson Eliot Officer (GENERAL COUNSEL & CORP. SEC.) Open-market sale −8,168 $9.65 $78,821
Jun 11, 2026 Karen K. Mcginnis Director Open-market sale −6,050 $8.01 $48,461
Jun 10, 2026 Karen K. Mcginnis Director Grant or award +32,012 — —
Jun 10, 2026 Quentin S. Blackford Director Grant or award +32,012 — —
Jun 10, 2026 Keith Valentine Director Grant or award +32,012 — —
Jun 10, 2026 David R. Pelizzon Director Grant or award +32,012 — —
Jun 10, 2026 David M. Demski Director Grant or award +32,012 — —
Jun 10, 2026 Mortimer Berkowitz III Director Grant or award +32,012 — —
May 11, 2026 Keith Valentine Director Open-market purchase +35,000 $7.00 $245,000
May 8, 2026 Keith Valentine Director Open-market purchase +43,847 $7.54 $330,606
May 7, 2026 Keith Valentine Director Open-market purchase +56,153 $7.49 $420,586
Apr 7, 2026 Marshall Tyson Eliot Officer (GENERAL COUNSEL & CORP. SEC.) Option exercise +15,000 $1.98 $29,700
Apr 7, 2026 Marshall Tyson Eliot Officer (GENERAL COUNSEL & CORP. SEC.) Option exercise +15,000 $1.68 $25,200
Apr 7, 2026 Marshall Tyson Eliot Officer (GENERAL COUNSEL & CORP. SEC.) Option exercise +12,500 $3.34 $41,750

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.